Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review

Lau, S.L.; Samman, N

doi:10.1016/j.ijom.2006.02.016

Cited by 200 publications

(189 citation statements)

References 57 publications

Supporting

Mentioning

162

Contrasting

Unclassified

Order By: Relevance

“…Non-radical surgical procedures, such as enucleation and curettage, are mentioned as useful in unicystic ameloblastomas, especially in children and young patients. Other treatment modalities have also been proposed, such as cryotherapy, electrocautery, sclerotherapy and radiotherapy 10 .…”

Section: Discussionmentioning

confidence: 99%

Radical management of aggressive lesions: a case report of recurrent ameloblastoma

Souza

Fé

Sousa

et al. 2015

RGO, Rev. Gaúch. Odontol.

View full text Add to dashboard Cite

RESUMOO ameloblastoma é um tumor odontogênico benigno, porém agressivo, de origem epitelial, constituindo cerca de 1-3% de todos os tumores e cistos da mandíbula. Apresenta crescimento lento e persistente, localizado na maior parte dos casos na área de ramo de mandíbula e ocasionalmente associado com terceiros molares inclusos. As lesões são caracterizadas por uma infiltração agressiva para o tecido adjacente e as células tumorais restantes podem levar a morbidades múltiplas de recorrência. Dessa forma, pode ocorrer uma elevada taxa de recorrência local se não for adequadamente removido. Este artigo relata um caso de ameloblastoma multicístico previamente tratado com terapia conservadora que resultou no insucesso do tratamento e recidiva da lesão após oito anos. O exame clínico demonstrou extensa reabsorção óssea na região de hemimandíbula direita. Foi realizada biópsia incisional e exame histopatológico para confirmação diagnóstica. O tratamento proposto foi a ressecção total em bloco envolvendo além de hemimandíbula direita, a região de elementos dentários 31 e 32 com margem de segurança de dois centímetros. O protocolo radical cirúrgico com boa margem de segurança deve ser a opção para prevenir a recidiva destes tumores agressivos.

show abstract

Section: Discussionmentioning

confidence: 99%

Radical management of aggressive lesions: a case report of recurrent ameloblastoma

Souza

Fé

Sousa

et al. 2015

RGO, Rev. Gaúch. Odontol.

View full text Add to dashboard Cite

show abstract

“…In the literature, recurrence after conservative (non-resection) treatment of conventional ameloblastoma ranges from 50 to 90 %. Recurrence after conservative treatment of unicystic ameloblastoma is reported to be between 10 and 25 % [4,13]. The use of Carnoy's solution to reduce the morbidity and recurrence rate in relation to unicystic ameloblastoma was initially suggested by Stoelinga and Bronkhorst in 1987 [3].…”

Section: Discussionmentioning

confidence: 99%

“…They showed that the critical time to nerve impairment of the rabbit inferior alveolar nerve was 3 min and it should not be directly applied over the nerve. Though there remains a need for human studies, the use of Carnoy's solution to reduce the recurrence rate should be balanced against the risk of nerve morbidity [5,13].…”

Section: Discussionmentioning

confidence: 99%

Carnoy’s in Aggressive Lesions: Our Experience

Rajeshkumar

Kumar

Geetha

et al. 2012

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

Carnoy's solution is used in the treatment of various aggressive cysts and tumors in the maxillofacial region as a chemical cauterizing agent. Its use has been extensively studied in case of odontogenic keratocysts. It is used in the management of unicystic ameloblastomas and ossifying fibromas. In our institution from 2006 to 2010 we have treated 14 cases of maxillofacial lesions using carnoy's solution. Among these cases 7 were of odontogenic keratocyst, 4 cases were of amelobalstoma and one case was of juvenile ossifying fibroma. So here we share our experience of treating these lesions with the carnoy's solution.

show abstract

“…a retrouvé 80 % de récidive après énucléation et curetage et moins de 50 % après traitement radical sur 50 cas étudiés [21] . Lau et Samman ont réalisé une étude pour déterminer le taux de récidive le plus bas après différents types de traitements de l'améloblastome unikystique : ils ont rapporté 3,9 % de récidive après résection, 30,5 % après énucléation seule, 16 % après énucléation + application d'une solution de Carnoy, et 18 % après marsupialisation avec ou sans autre traitement associé [22] . Une autre étude réalisée par Payam Farzad sur 8 cas d'améloblastome (7 mandibulaires et 1 maxillaire) : 4 traités par énucléa-tion ou curetage, 1 cas par résection non interruptrice et 2 cas par hémimandibulectomie.…”

Section: Discussionunclassified

“…Par contre, Bataille et coll. considèrent que si l'indication de la méthode conservatrice est bien posée et si la chirurgie bien menée, le traitement conservateur garde sa place même si elle n'est plus la première dans le traitement des améloblastomes [19][20][21][22][23][24][25] . …”

Section: Discussionunclassified